Mbd4 and MutSα protect cells from spontaneous deamination of 5-methylcytosine
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkaf1493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Rebecca A Bilardi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute, 1G Royal Pde, Parkville, VIC 3052, Australia. Hauptthemen laut MEDLINE: 5-Methylcytosine, Endodeoxyribonucleases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Leukaemia Foundation, SERP, NHMRC.
Abstract (Originalsprache)
5-Methylcytosine (5mC) is a common source of somatic mutations. Deamination of 5mC to thymine generates a G/T mismatch, which occurs spontaneously and must be repaired prior to DNA replication to avoid mutation. We generated genetically engineered mice and cell lines to define DNA repair pathways that protect against 5mC deamination. We observed a low background mutation rate in mouse bone marrow or colon, typically 0.2–0.5 CG > TG mutations/genome/day. This increased 3–7 fold in cells lacking the glycosylase methyl-binding domain 4 (Mbd4), one of the few glycosylases capable of excising thymine from G/T mismatches. We found no role for thymine DNA glycosylase (Tdg) in the repair of 5mC deamination in these tissues. Instead, our results flag potential cooperation between Mbd4 and the mismatch repair (MMR) complex MutSα (Msh6:Msh2), evident through elevated rates of CG > TG mutations in Msh6-deficient cells: 2.6–4.8 CG > TG mutations/genome/day in primary cells and 13.9 CG > TG mutations/genome/day in cell lines. Loss of Mbd4 results in a specific increase in DNA damage from 5mC deamination, whereas the broader functionality of MutSα explains why mutational signatures linked to Msh6 deficiency are more variable and reflect the replicative history of the cell. Our findings support the emerging view that MutSα has broader DNA repair activity outside of replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute, 1G Royal Pde, Parkville, VIC 3052, Australia.
- Department of Medical Biology, University of Melbourne, 1G Royal Pde, Parkville, VIC 3052, Australia.
- Cancer Immunology Program, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.
- Olivia Newton-John Cancer Research Institute, 145 Studley Rd, Heidelberg, VIC 3084, Australia.
- School of Cancer Medicine, La Trobe University, Plenty Rd, Bundoora, VIC 3083, Australia.
ORCID-Profile: Ian J Majewski
Förderung
- Leukaemia Foundation
- SERP
- NHMRC
- WEHI
- IRIISS
- National Collaborative Research Infrastructure Strategy
- NCRIS
Zitieren
APA
Bilardi, R. A., Flensburg, C., Xu, Z., Derrick, E. B., Kueh, A., & Majewski, I. J. (2026). Mbd4 and MutSα protect cells from spontaneous deamination of 5-methylcytosine. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1493
Vancouver
Bilardi RA, Flensburg C, Xu Z, Derrick EB, Kueh A, Majewski IJ. Mbd4 and MutSα protect cells from spontaneous deamination of 5-methylcytosine. Nucleic Acids Research. 2026. doi:10.1093/nar/gkaf1493
BibTeX
@article{Bilardi2026,
author = {Bilardi, Rebecca A and Flensburg, Christoffer and Xu, Zhen and Derrick, Emily B and Kueh, Andrew and Majewski, Ian J},
title = {Mbd4 and MutSα protect cells from spontaneous deamination of 5-methylcytosine},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkaf1493}
}
EUVIMED